MASHINIi

Rapid Micro Biosystems, Inc..

RPID.US | Research and experimental development on natural sciences and engineering

Rapid Micro Biosystems, Inc. is a commercial biotechnology company providing innovative products for fast, accurate, and efficient detection of microbial contamination in biopharmaceutical manufacturing. Their Growth Direct platform automates and accelerates traditional microbial testing methods, of...Show More

Ethical Profile

Mixed.

Rapid Micro Biosystems (RPID.US) presents a mixed ethical profile. While Indeed.com reviews show high employee satisfaction (4.5/5 overall, 4.6 for pay/benefits/culture), Glassdoor.com reports suggest a 20-25% employee turnover rate, with some critics pointing to a toxic work environment. The company positively contributes to public health by providing its FDA-compliant Growth Direct system, used by a majority of top 20 global pharmaceutical companies, to enhance quality control and ensure the safety of critical medicines like vaccines and cell therapies. RPID maintains a code of business conduct, a confidential compliance hotline, and a no-retaliation policy. However, comprehensive data on areas like ethical sourcing, environmental impact, and tech safety remains largely unavailable.

Value Scores

Better Health for All50
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect20
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business20
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products-40
-100100

Better Health for All

50

Rapid Micro Biosystems' core product, the Growth Direct System, is used by a majority of the top 20 global pharmaceutical companies.

1
This technology aims to improve data integrity, reduce errors, increase efficiency, and decrease the risk of contamination and product recalls in biopharmaceutical manufacturing, including biologics, vaccines, and cell & gene therapies.
2
This fundamentally improves the safety and robustness of the global pharmaceutical manufacturing ecosystem. The company's business model is entirely focused on ensuring the safety and quality of pharmaceuticals, with no evidence of products having negative health outcomes. The Growth Direct System is FDA-compliant with 21 CFR Part 11, demonstrating adherence to regulatory standards for electronic records and signatures.
3
The company raised $81 million in equity financing in 2021, contributing to over $340 million in total equity raised, which supports its continued innovation in health-improving technologies.
4

Fair Money & Economic Opportunity

0

No evidence available to assess Rapid Micro Biosystems, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

20

Rapid Micro Biosystems states that none of its employees are covered by a collective bargaining agreement.

1
The company provides its employees with competitive health and welfare benefits, including short-term and long-term disability insurance, 401k, employee stock purchase plan (ESPP), pet insurance, and paid time off.
2
With 163 full-time employees as of December 31, 2024, the company offers 100% health insurance coverage, including dependents and mental-health services.
3
Employee reviews on Indeed.com indicate an overall rating of 4.5 out of 5 stars, with a 4.6 out of 5 stars for culture and 4.6 out of 5 stars for management.
4
However, Glassdoor reviews indicate a high employee turnover rate of 20% or 25%.
5

Fair Trade & Ethical Sourcing

0

The provided articles do not contain specific, quantifiable evidence for any of the KPIs under the 'Fair Trade & Ethical Sourcing' value. While some articles mention general commitments to ethical conduct, compliance with anti-bribery laws (like the FCPA and UK Bribery Act)

1
, and internal codes of conduct
2
, they lack concrete data points such as the percentage of fair-trade certified spend, average audit frequency for suppliers, number of forced or child labor incidents, traceability coverage for suppliers, remediation speed for supplier violations, or the percentage of contracts with enforceable ethical sourcing clauses.
3
Therefore, no KPIs can be scored based on the available information.

Honest & Fair Business

20

The company provides a confidential Compliance Hotline and online portal that are available 24/7 in multiple languages, and it has a no retaliation policy in place.

1
The Compliance Hotline is operated by an independent company.
2
However, there is no evidence regarding the extent of independent verification for other ethical claims or compliance.

Kind to Animals

0

No explicit information or specific data points regarding RPID.US's practices related to animal welfare, animal testing, animal-derived ingredients, or conservation efforts were found across the provided articles. Therefore, no KPIs can be scored.

No War, No Weapons

0

No evidence available to assess Rapid Micro Biosystems, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No evidence available to assess Rapid Micro Biosystems, Inc. on Planet-Friendly Business.

Respect for Cultures & Communities

0

The provided articles do not contain specific, quantifiable evidence to assess Rapid Micro Biosystems, Inc. against any of the defined KPIs for 'Respect for Cultures & Communities'. While the company has a Compliance Hotline and online portal available in multiple languages,

1
and internal channels for reporting code violations,
2
the evidence does not specify these as mechanisms for 'community concerns' or provide coverage as a percentage of operational sites. Information regarding formal partnerships with community groups, revenue reinvested locally, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, community governance inclusion, cultural preservation investments, local procurement, indigenous suppliers, cultural site protection, social license to operate, charitable giving to cultural organizations, community fund allocation, language inclusivity in products/communications, cultural incident response, or cultural sensitivity training completion is not available.
3

Safe & Smart Tech

0

Rapid Micro Biosystems has upgraded its reporting and auditing to comply with 21 CFR Part 11, a regulation relevant to electronic records and electronic signatures in the pharmaceutical industry.

1

Zero Waste & Sustainable Products

-40

The company's operations involve materials and produce waste that could be hazardous, and it states that federal, state, and local laws and regulations govern the handling and disposal of these materials.

1
The company has not received any regulatory citations during routine audits of customer sites for its technology.
2
Growth Direct systems are designed to be used for many years, indicating good product durability.
3
However, there is no specific evidence of the company's own waste reduction initiatives or efforts to minimize hazardous waste beyond basic compliance.

Own Rapid Micro Biosystems, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.